Melinda Ann Brindley - Infectious Diseases

Author Information

Melinda Ann Brindley is a distinguished researcher affiliated with the Department of Infectious Diseases, Department of Population Health, and the Center for Vaccines and Immunology at the College of Veterinary Medicine, University of Georgia in Athens, Georgia, USA. Her expertise in infectious diseases is evident through her significant contributions to the field, particularly in understanding viral behavior and vaccine development.

Research Contributions

Melinda Ann Brindley has made substantial contributions to the study of infectious diseases, with a focus on viral replication and vaccine efficacy. Her recent works include the investigation of Zika virus genome replication under temperate conditions, the comparison of seroprotection against SARS-CoV-2 variants using different vaccines, and the impact of phosphatidylserine on Chikungunya virus infectivity. Her research extends to evaluating the replication and pathogenicity of the SARS-CoV-2 Omicron variant and enhancing the efficacy of SARS-CoV-2 vaccines through immunosuppressant drug modulation. Melinda's work is pivotal in the ongoing efforts to combat viral infections and improve vaccine responses.

Aliases

Melinda Ann Brindley is also known by several aliases including M. A. Brindley, Melinda Brindley, Melinda A Brindley, and Melinda A. Brindley.

Publication and Citation Metrics

Metric Value
Total Papers 73
Total Citations 3180
h-index 29

Publications:

DOI: 10.1128/jvi.00165-22

Year: 2022

Partnered Content Networks

Relevant Topics